Effect of a high intake of cheese on cholesterol and metabolic syndrome: results of a randomized trial.

ABSTRACT:

Background

Cheese is generally rich in saturated fat, which is associated with increased risk for cardiovascular diseases. Nevertheless, recent reports suggest that cheese may be antiatherogenic.

Objective

The goal of this study was to assess whether intake of two types of Norwegian cheese, with widely varying fat and calcium content, might influence factors of the metabolic syndrome and serum cholesterol levels differently.

Design

A total of 153 participants were randomized to one of three groups: Gamalost(®), a traditional fat- and salt-free Norwegian cheese (50 g/day), Gouda-type cheese with 27% fat (80 g/day), and a control group with a limited cheese intake. Blood samples, anthropometric measurements, blood pressure, and questionnaires about lifestyle and diet we

SUBMITTER: Nilsen R 

PROVIDER: S-EPMC4543447 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature